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ABSTRACT 
The varicella-zoster virus (VZV) causes chickenpox or varicella, a disease primarily in children, 
and Herpes Zoster (HZ) or zoster or shingles, a disease that affects adults.  A 2-dose Varicella 
vaccination is recommended in the United States, the first dose at age 15-18 months and the 
second dose at 4 to 6 years. In this study, we used multinomial logistic regression to analysis 
data from the 2011 National Immunization Survey-Teen (NIS-Teen) to identify factors that have 
a significant impact on the number of doses (0-dose, 1-dose, or 2-dose) a teen will have.  We 
evaluate Varicella vaccination coverage stratified by Census region and assessed factors 
independently associated with varicella vaccination. 
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1 INTRODUCTION 
1.1 Purpose of the Study 
Varicella became a nationally notifiable disease in the United States in 1972. It took twenty-three 
years later, in 1995, for the first varicella vaccine to be licensed for use in the United States.  
Immediately following this, a single dose of varicella was recommended for routine childhood 
vaccination in 1996. Exactly ten years later, in 2006, two doses of the varicella vaccine was then 
recommended again routinely as part of the childhood vaccination schedule in the United States.8  
The varicella-zoster virus (VZV) causes chickenpox or varicella, a disease primarily in children, 
and Herpes Zoster (HZ) or zoster or shingles, a disease that affects adults and 
immunocompromised individuals predominatly.3 The VZV could have serious health hazards for 
babies, adults, and people with weakened immune systems. It spreads easily from infected 
people to others who have never had chickenpox or received the chickenpox vaccine. 
Chickenpox spreads in the air through coughing or sneezing. It can also be spread by touching or 
breathing in the virus particles that come from chickenpox blisters.  It takes about ten to twenty-
one days after coming into contact with someone who has the disease, for you to show any clear 
signs of being infected. An early sign of chickenpox infection includes rashes on the upper body. 
These rashes later develop into blisters, and then blisters form scabs. Others infected could also 
develop fever, anorexia and malaise.3  
Before the introduction of a varicella vaccination program in the US, about 10,600 people were 
hospitalized, out of about 4 million cases of chickenpox reported in the US per year. This led to 
about 100 to 150 deaths annually as a result of chickenpox.1,3  About 90%  of the population who 
contracted chickenpox were children below 15 years.1 Also, the hospitalization rate of varicella 
infection for adults 20 years and older was surprisingly about thirteen times that of children 
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between the ages of 5 and 9 years.1,9  Furthermore, the hospitalization rate of infants less than a 
year old was about six times that of the 5 though 9 year group.1,9   
The best way to prevent chickenpox is to receive the chickenpox vaccine. The vaccine is made 
from weakened varicella virus that produces an immune response in your body that protects you 
against chickenpox. The chickenpox vaccine was first used in Japan and Korea in 1988 and in 
1995, the Advisory Committee on Immunization Practices (ACIP) recommended a routine 1-
dose vaccination program. The United States became the first country to introduce a universal 
childhood vaccination program.1 
The target group of the 1-dose program was primarily healthy 12 to 18 months and a catch-up 
vaccination of some older children and adolescents as well.2 It’s well documented that varicella –
incidence decreased by approximately 90% following the introduction of the 1-dose program.2 
The era of the 1-dose program also caused decline in varicella-related hospitalizations and 
deaths.3,4  In 2006, the ACIP  and the American Academy of Pediatrics recommended a universal 
2-dose program.16,17  The first dose was recommended for healthy children at age 12 to 15 
months and the second dose 4 to 6 years of age due to a significant number of break-through 
chicken pox as wells as outbreak of new chicken pox diseases.1,5  More studies seem to confirm a 
further decline in varicella-incidence. 5,20 
In this study, we used multinomial logistic regression to analyze data from the 2011 National 
Immunization Survey-Teen (NIS-Teen) to identify factors that have a significant impact on the 
number of doses (0-dose, 1-dose, or 2-dose) a teen will have.  We evaluate Varicella vaccination 
coverage stratified by Census region and assessed factors independently associated with varicella 
vaccination. 
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1.2 Source of Data 
A total of 19,144 completed household interviews comprised the National Immunization 
Survey (NIS) data for 2011. Surveys were counted as part of the total if they had sufficient health 
records from their healthcare providers. Out of this total, 16,919 were conducted through 
landline telephones and 2,225 were conducted through cell phones for the very first time. Also, 
1,445 out of the 2,225 cell phone survey participants belonged to homes that did not have any 
landline telephones.  
The 2011 NIS – Teen data, however, included a total of 23,564 household interviews that 
were complete because teen or parent/guardian had been interviewed over the phone as well as 
health data from their healthcare providers. Out of the total of 23,564 adolescents, 12,328 males 
and 11,236 females. The response rate for the landline interviews was 57.2% and the response 
rate for the cellphone interviews was 22.4%. 
                 The 2011 NIS-Teen used a random-digit dialed-sample of landlines and cellphones to 
reach teens and/or their parents/guardians between July and September 2011 to collect 
vaccination information for 13-17 year olds (born during January 1993 through February 1999) 
in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands. Six areas 
that received federal Section 317 immunization grants were sampled separately: These six areas 
the District of Columbia; Chicago, Illinois; New York, New York; Philadelphia County, 
Pennsylvania; Bexar County, Texas; and Houston, Texas receive Federal Section 317 
Immunization Grants. These six areas were sampled separately. The data for teens from the U.S. 
Virgin Islands are not part of the NIS-Teen data used in the thesis analysis.   
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During the survey, parents/guardians provide vaccination and other pertinent sociodemographic 
information on the 13-17 years olds living with them. During the interview/survey, permission is 
sought from parents/guardians to contact their teen’s healthcare provider. A questionnaire/survey 
is then mailed to that provider to obtain a vaccination history from the teen’s medical record. A 
total of 23,564 adolescents (12,328 males and 11,236 females) are included in the national 
estimates. The information obtained from the primary care providers were very reliable and 
accounted for 61.5% of the entire NIS-Teen data.6      
To make adjustments for households with multiple phone lines, households with both landlines 
and cellphone, households with no phones and households who never answered their phones, 
weights were employed to the raw data.  
We then used logistic regression to analyze the data for significant factors.  
 Statistical analyses were conducted using SAS callable SUDAAN Release 11.0 (RTI, RTP,  
NC) to account for the complex sampling design; weighting was applied for the estimates to be  
representative of the census regions.  
Statistical analyses were conducted using t-tests based on weighted data and accounting for the 
complex survey design. A p-value of <0.05 was considered statistically significant. 7 
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2 RESEARCH METHODOLOGY 
2.1 Multinomial Logistic Regression  
Multinomial Logistic Regression (MNLR), simply put, is an extension of binary logistic 
regression with multiple explanatory variables.  MNLR is also referred to as the Multinomial 
Logit as well as the Polytomus Logistic Regression, since it is used to model the relationship 
between a polytomous response variable and a set of independent variables. The polytomous 
response could be ordinal (ordered categories) or nominal (unordered categories).  
The MNLR model permits the comparison of more than one contrast simultaneously. In 
both MNLR and ordinary logistic regression, the impact of predictor variables are explained in 
terms of the odds ratio. In logistic regression, the categorical response has only two values. 
Generally, 1 is for success and 0 for failure. Logistic regression uses a logit function to link the 
probability of success and predictors, and applies maximum likelihood estimation method to 
estimate parameters.   
The multinomial logit compares multiple groups through a combination of binary logistic 
regressions.15 This allows each category of the dependent variable to be compared to a reference 
category. Normally, the category with the highest numeric score is chosen as the reference 
category. As a general rule, when there are, say, n possible levels of the dependent variable, the 
MNLR model will consist of  n – 1 equations.  
The logistic regression extends to models with multiple predictors. For example, the 
model with π(x) =  P(Y=1)|x1, x2, …..,xk )  is given by 
1 1 2 2
( )
( ( )) log ......
1 ( )
p p
x
Logit x x x x
x

    

 
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 
      (3.1)
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The parameter βi refers to the effect of xi on the log odds that Y=1, controlling the other 
xj. For example, exp(βi) is the multiplicative effect on the odds of a 1-unit increase in xi, at fixed 
levels of other xj. A predictor can be qualitative, using dummy variables for categories.  
The alternative formula, directly specifying   π(x),  is given  by 
1 1 2 2
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Also, if there are n independent observations with p predictors and the qualitative 
response variable has k categories, then one of the categories must be chosen as the reference 
level, and all other logits in the multinomial case will be constructed relative to this reference 
level. Pretty much, any category can be selected as the base or reference level. Since there is no 
ordering, we would select category k as base level. In this case, πj will denote the multinomial 
probability of an observation falling in the jth category.  The multiple logistic regression model 
below will now depict the relationship between this multinomial probability πj and the p 
predictors  X1, X2, …..,Xp 12 
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where  j  = 1, 2, …..,(k-1);    i = 1, 2, …, n.  Since   
j
j x 1)(  , the model reduces to 
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Here  πj(x) = Prob (Y = j | x1,x2,…,xp)  at a fixed setting x for predictors.  
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In our study the dependent variable is number of varicella shots obtained, and we are 
interested in the probability of a United States teen falling into one of the following options 
        1. [0-dose] or no vaccination      
       2.  [1-dose] or partial vaccination     
       3. [2-dose] or full vaccination 
The analysis would then compare teens that had [0-dose] relative to [2-dose] and teens 
who had [1-dose] relative to [2-dose].  The MNLR model for 3 options for the number of 
varicella shots can be represented by these two logistic models.  
Let p denote the number of predictors for the binary response Y by x1, x2, …..,xp. The 
two equations for the MNLR model is given by  
10 11 1 12 2 1
Pr( 0)
......
Pr( 2)
p p
Y
Log x x x
Y
   
 
     
 
                           (3.5) 
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Log x x x
Y
   
 
     
 
                         (3.6) 
2.2 Model Assumptions 
In any logistic regression, the observations are assumed to be independent. The response 
variable is assumed to have a multinomial distribution, and the probabilities are linked to the 
predictors with logit link functions. The logits are assumed to be linear related to independent 
variables.  
 To get good result from multinomial logistics analysis, it is recommended that your data 
needs to large. At least 10 cases for each individual variable are required. Some statisticians 
actually recommend 30 cases per each variable. Multicollinearity problems can be addressed by 
either centering the variables or employing the method of factor analysis.    
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3 RESULTS 
3.1  Descriptive Statistics of All Variables 
In this section of the study, the Varicella data extracted from the NIS-Teen Survey data 
for 2011 to begin the analysis to compare the proportion of the doses of Varicella shots for each 
of the variables and then conduct a multinomial logistic regression analysis.  
Table 3.1 Sample Characteristics by Demographic Variables of Participants Aged 
13 - 17 Years in the United States 
NIS-TEEN, 2011 for  Varicella Shots 
 
  0-Dose 1-Dose 2-Dose 
TOTAL 23,564 912 3,488 10,208 
GENDER     
Male 12,328 435 1,805 5,415 
Female 11,236 477 1,683 4,793 
AGE     
13 4,763 131 807 2,725 
14 4,842 126 724 2,489 
15 4,750 198 701 2,104 
16 4,774 203 718 1,698 
17 4,435 254 538 1,192 
RACE AND ETHNICITY     
Non-Hispanic White 15,970 574 2,418 6,708 
Non-Hispanic Black or African American 2,408 138 392 1,112 
Hispanic or Latino 3,234 127 420 1,498 
Non-Hispanic Other & Multiple Race 1,952 73 258 890 
POVERTY STATUS     
Below Poverty Level 11,406 344 1,572 5,414 
At Or Above Poverty Level 12,158 568 1,916 4,794 
MOTHER'S EDUCATION STATUS     
Less Than High School 2,227 129 363 907 
High School 4,581 229 726 1,732 
> High School, College Non-Grad 6,463 272 1,001 2,593 
College Graduate 10,293 282 1,398 4,976 
MOTHER'S MARITAL STATUS     
Married 17,690 624 2,586 7,753 
Never 
Married/Divorced/Widowed/Separated/Deceased 5,874 288 902 2,455 
MOTHER'S AGE GROUP     
≤34 years 1,716 83 314 787 
35-44 years 9,674 392 1,486 4,135 
≥45 years 12,174 437 1,688 5,286 
CENSUS REGION     
Northeast 4,619 85 525 2,503 
Midwest 4,997 217 669 1,962 
South 8,771 356 1,504 3,698 
West 5,177 254 790 2,045 
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From Table 3.1, of the 23,564 participants in the survey, males represented 52.3% and females 
represented 47.7% .  Also, 13-year olds accounted for 20.2%, 14-year olds accounted for 20.5%, 
15-year olds accounted for 20.2%, 16-year olds accounted for 20.2% and 17-year olds accounted 
for the remaining 18.8% of the total number of respondents.  The survey comprised 67.8% 
Whites, 13.7% Hispanics, 10.2% Blacks and 8.3% made up of other/multiple races.  
Additionally, 75.1% of the respondents were married and 24.9% were unmarried.  Table 1 also 
indicates that 7.3% of the mothers of the teen respondents were 34 years and below, 41.1% were 
between the ages of 34 years and 44 years, and the remaining  51.7% of the mothers were 45 
years and older.  The demographics of the census region included 19.6% in the North-East, 
21.2% from the Mid-West, 37.2% from the South and the remaining 22% from the West.  
The state of Texas had the highest percentage of respondents, accounting for 9.4% o the total 
number of survey participants. Each of the remaining 49 states plus the District of Columbia 
accounted for less than 4% of the total.  
For the overall survey respondents, 67.6% had the required 2-does Varicella shots, 24.5% had 1-
dose Varicella shots and 7.9% had  0-dose Varicella shots.  For males, , 69.6% had the required 
2-does Varicella shots, 23.4% had 1-dose Varicella shots and 7.0% had  0-dose Varicella shots. 
For females, , 65.6% had the required 2-does Varicella shots, 25.6% had 1-dose Varicella shots 
and 8.7% had  0-dose Varicella shots. 
For the age groups, 73.9% of 13-year olds, 73% of 14-year olds, 66.3% of 15-year olds, 63.2% 
of 16-year olds, and 56.7% o 17-year olds had the 2-Dose Varicella shots, signifying a sharp 
drop in the percentage in the 2-dose Varicella shots as age increases. Consequently there is a rise 
in both the percentages that had 0-dose and 1-dose as age of teens increase.  
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For race categories, the O-dose percentage for each of the 4 types of race is less than 10%, 
meaning the combined 1-dose and 2-dose percentages are each above a remarkable 90%. Each of 
the 4 categories of race has a 2-dose percentage of more than 64% and a 1-dose percentage of 
more 19% .   
For household income levels below the poverty line, 71.7% had 2-dose Varicella shots and 
22.8% had 1-dose shots while 65.1% had 2-dose Varicella shots and 25.6% had 1-dose shots for 
income levels equal to or above the poverty line.   
For mother’s education level, it looks like the more schooling a mother has, the higher the 
percentage who got 2-doses evidenced by 73.2% for College Graduate moms, 64% for more than 
High school graduate moms, 64.7% for High school graduate moms and 65.8% for less than high 
school moms.  
Concerning marital status, 69.4% had 2 –doses and 23.8% had 1-dose and 6.8% had 0-dose for 
teens whose moms were married. It was 64.2% 2-dose, 25.9% 1-dose and 9.9% 0-dose for teens 
whose mothers were unmarried.  
The percentage for 2-dose Varicella shots for teens whose mothers were older (45 years and 
above) was 69.3% slightly higher than teens whose mothers were less than 45 years (66.8% for 
mothers between 35 and 44 years; and 64.8% for mothers 34 years and younger.  
Finally, for the 4 census regions, the North-East possessed the highest percentage(76.4%)  for 2-
dose shots completed, followed by the Mid-West with 68.9% success rate for 2-doses, then the 
South with 64.6% and last but not least, the West with 64.3% success rate for 2-dose varicella 
shots.    
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3.2   Analysis of Univariate Data 
The estimates and corresponding p-values under unadjusted model in Table 3.2 involves running 
the model where each variable happens to be the only predictor in the model at each time.  
From Table 3.2, according to unadjusted model, for a one unit increase in sex (i.e going from 
female to male),  the odds of obtaining a 1-dose varicella shot versus 2-dose shot changes 
multiplicatively by 0.9. The Wald statistic = 7.636 with P-value of 0.0216, implying the effect of 
sex is significant.  
From Table 3.2, according to unadjusted model, for a one unit increase in age (i.e  going from 17 
to 13), the odds of obtaining a 1-dose varicella versus 2-dose shot changes multiplicatively by 
0.6.  Also, for a one unit increase in age (i.e. from 17 to 13), the odds of obtaining a 1-dose 
varicella shot versus 2-dose shot changes multiplicatively by 0.2 for the unadjusted model.  Also, 
for a one unit increase in age (i.e. going from 17 to 15), the odds of obtaining a 1-dose varicella 
shot versus 2-dose shot changes multiplicatively by 0.7 for the unadjusted model. And finally, 
according to the unadjusted model, for a one unit increase in age (i.e. going from 17 to 16), the 
odds of obtaining a 1-dose varicella shot versus 2-dose shot changes multiplicatively by 0.9. The 
Wald statistic is 114.147 with P-value less 0.001, implying the effect of age is significant.  
The same analogy can be made for the variables race & ethnicity, poverty status, mothers’ 
education status, mothers’ marital status, US census region and all the 50 states. All of these 
variables are significant from the unadjusted models.  
For mothers’ age group, the unadjusted models indicate it is not significant in predicting 0-dose, 
1-dose or 2-doses.  
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Table 3.2 Weighted Estimates of Odds Ratios of Vaccination Status by Demographic 
Variables of Participants Aged 13 - 17 Years in the United States 
NIS-TEEN, 2011 
 
 0-Dose to 2-Dose 1-Dose to 2-Dose 
 Unadjusted  Adjusted Unadjusted Adjusted 
TOTAL     
GENDER     
Male 0.8 ** 0.7 ** 0.9** 0.9 ** 
Female REF REF REF REF 
AGE     
13 0.2 ** 0.2 ** 0.6 ** 0.6 ** 
14 0.2 ** 0.2 ** 0.7 ** 0.6** 
15 0.5 ** 0.5 ** 0.7 ** 0.7 ** 
16 0.6 ** 0.5 ** 0.9 ** 0.9 ** 
17 REF REF REF REF 
RACE AND ETHNICITY     
Non-Hispanic White REF REF REF REF 
Non-Hispanic Black or African American 1.3 ** 1.0  1.1 ** 0.9  
Hispanic or Latino 1.2** 0.8  0.7** 0.6 ** 
Non-Hispanic Other & Multiple Race 0.9 ** 0.7  0.8 **g 0.7** 
POVERTY STATUS     
Below Poverty Level 0.5** 0.7** 0.8 ** 0.9  
At Or Above Poverty Level REF REF REF REF 
MOTHER'S EDUCATION STATUS     
Less Than High School 1.8 ** 1.2  1.3 ** 1.4 ** 
High School 2.1 ** 1.7 ** 1.3** 1.3 ** 
> High School, College Non-Grad 1.7 S** 1.3 1.5 ** 1.4 **g 
College Graduate REF REF REF REF 
MOTHER'S MARITAL STATUS     
Married REF REF REF REF 
Never 
Married/Divorced/Widowed/Separated/Deceased 1.6 ** 1.3  1.2 ** 1.1  
MOTHER'S AGE GROUP     
≤34 years 1.2  1.2  1.2  1.2  
35-44 years 1.2  1.2  1.1  1.1  
≥45 years REF REF REF REF 
CENSUS REGION     
Northeast REF REF REF REF 
Midwest 3.0 ** 3.2 ** 1.2 ** 1.2  
South 2.7 ** 2.8 ** 1.6 ** 1.6 ** 
West 4.3 ** 5.1 ** 1.4 **    1.6   
 
 
 
 
 
** Odds ratios are significant at P-value < 0.05 
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3.3 Analysis of Multiple Logistic Regression Data                                                      
Categorical independent variables have been added as a series of dummy dichotomous variables.  
Each independent variable has a reference category, identified in the tables as “REF”.  In 
interpretation of the results as it relates to obtaining either 0-dose, or 1-dose or 2-dose is not 
affected by the choice of the reference category. The estimates and corresponding p-values under 
adjusted model in Table 3.2 involves running the model with all the variables present and then 
holding them constant as needed.   
From Table 3.2, according to adjusted models, for a one unit increase in sex (i.e. going from 
female to male), the odds of obtaining a 1-dose varicella shot versus 2-dose varicella shot 
changes multiplicatively by 0.9. The Wald statistic = 4.74 with P-value of 0.0294, implying the 
effect of sex is significant.  
 Also, for a one unit increase in sex (i.e. from female to male), the odds of obtaining a 1-dose 
varicella shot versus 2-dose shot changes multiplicatively by 0.9. The Wald statistic = 4.134  
with P-value of 0.042, implying the effect of sex is significant.  
From Table 3.2, according to adjusted models, for a one unit increase in age (i.e. going from 13 
to 14), the odds of obtaining a 1-dose varicella shot versus 2-dose shot changes multiplicatively 
by 0.6. The Wald statistic = 20.19 with P-value less than 0.0001, implying the effect of age is 
significant.  
Also, for a one unit increase in age (i.e. from 13 to 14), the odds of obtaining a 0-dose varicella 
shot versus 2-dose shot changes multiplicatively by 0.2.  The Wald statistic = 75.77 with P-value 
less than 0.0001, implying the effect of age is significant.  
Similarly, according to adjusted models, for a one unit increase in age (i.e. going from 13 to 14), 
the odds of obtaining a 1-dose varicella shot versus 2-dose shot changes multiplicatively by 0.6. 
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The Wald statistic = 57.37 with P-value less than 0.0001, implying the effect of age  is 
significant.  
Also, for a one unit increase in age (i.e. from 13 to 14), the odds of obtaining a 0-dose varicella 
shot versus 2-dose shot changes multiplicatively by 0.2. The Wald statistic = 64.49 with P-value  
less than 0.0001, implying the effect of age category  is significant.  
Also, according to adjusted models, for a one unit increase in age (i.e. going from 13 to 14), the 
odds of obtaining a 1-dose varicella shot versus 2-dose changes multiplicatively by 0.7 The Wald 
statistic = 9.77  with P-value of 0.016, implying the effect of age is significant.  
Also, for a one unit increase in age, the odds of obtaining a 0-dose varicella shot versus 2-dose 
shot changes multiplicatively by 0.5. The Wald statistic = 12.475 with P-value of 0.004, 
implying the effect of age category is significant.  
And finally, according to adjusted models, for a one unit increase in age, the odds of obtaining a 
1-dose varicella shot versus 2-dose shot changes multiplicatively by 0.9.  The Wald statistic = 
1.243 with P-value of 0.2649, implying the effect of this age category is not significant.  
Also, for a one unit increase in age, the odds of obtaining a 1-dose varicella shot versus increases 
multiplicatively by 0.5.  The Wald statistic is 11.897 with P-value less 0.006, implying the effect 
of age category is significant.19 
The same analogy can be made for the variables race & ethnicity, poverty status, mothers’ 
education status, mothers’ marital status, US census region and all the 50 states. Some categories 
of these variables are not significant since the corresponding p-values associated with the Wald 
statistic are greater than the predefined alpha-value of 0.05.  
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Table 3.2 also indicates that in the adjusted model, females are over 43 % more likely to receive 
0-dose than 2-doses (1/0.7 = 1.43) and over 11% (1/0.9=1.11) more likely to receive 1-dose 
Varicella shots than 2-dose requirement compared to men. Also, 17 year olds are about 400% 
(1/0.2 = 5), 400% (1/0.2=5), 100%  (1/0.5=2) and 100%  (1/0.5=2)  more likely to receive the 1-
dose Varicella shots than complete the 2-dose compared to 13-year, 14-year, 15-year and 16-year 
olds respectively.  Also, 17 year olds are again 67% (1/0.6 = 1.67) , 67% , 43% (1/0.7=1.43), 
11%  (1/0.9=1.11) more likely to receive the 1-dose  requirement than the 2 –dose compared to 
13-year, 14-year, 15-year and 16-year olds respectively. In terms of race, from Table 3.2, Whites 
are 67%  (1/0.6=1.67) and 43% (1/0.7=1.43) more likely to receive the 1-dose Varicella shots 
than complete the 2-dose compared to Blacks/African-Americans and Other Races/Multiple 
Races. For significance of education, high school graduates are 20% (Odds Ratio = 1.2)  more 
likely to obtain a 0-dose than 2-doses compared to college graduates. More than a high school 
education makes you 40 % more likely, high school graduates are 30% more likely, and less than 
a high school education makes you 40% more likely to obtain a 1-dose than a 2-dose compared 
to college graduates. Marriage also has a significant impact on vaccine status. A mother who has 
never being married or divorced or separated or deceased  makes her teen 30% more likely to get 
a 0-dose compared to a 2-dose, and 10%   more likely to get a 1-dose compared to a 2-dose, 
compared to being married.  
Age category has no significant impact on vaccine status.  
Finally, all 4 census regions are significant contributors to the vaccine status.  
We next take a look at multiple logistic regressions for determining vaccine status by stratifying 
the data according to the 4 census regions. From Table 3.3(a) and 3.3(b) , males are 30% , and 
over 26%  (Odds Ratio = 0.741) , less likely to obtain a 1-dose Varicella shot opposed to a 2-
16 
dose Varicella shot compared to females in the West and South regions respectively. Also, 13 
year olds are about 87%  (Odds Ratio = 0.129), about 90% (Odds Ratio = 0.097), about 67% 
(Odds Ratio = 0.326) and about 80% (Odds Ratio = 0.194), less likely to obtain a 0-dose 
varicella shot as opposed to a 2-dose Varicella shot compared to 17 year olds in the South, West, 
Northeast and Midwest regions. Also, 14 year olds are about 40%  (Odds Ratio = 0.591), about 
90%  (Odds Ratio = 0.098), about 86%  (Odd Ratio = 0.136),  and about 74% (Odds Ratio = 
0.257) less likely to obtain a 0-dose Varicella shot as opposed to a 2-dose Varicella shot 
compared to 17 year olds in the South, West, Northeast and Midwest regions respectively. 
Also, 14 year olds are about 44% (Odds Ratio = 0.556), and about 50% (Odds Ratio = 0.496), 
less likely to obtain a 1-dose Varicella shot as opposed to a 2-dose Varicella shot compared to 17 
year olds in the West and South regions respectively. 
Also, 15 year olds are about 33%  (Odds Ratio = 0.674), and about 48%  (Odds Ratio = 0.552) 
less likely to obtain a 1-dose Varicella shot as opposed to a 2-dose Varicella shot compared to 17 
year olds in the South and  West regions respectively.  
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 NORTHEAST REGION MIDWEST REGION 
 0-Dose to 2-Dose 1-Dose to 2-Dose 0-Dose to 2-Dose 1-Dose to 2-Dose 
TOTAL     
GENDER     
Male 0.969  1.085  1.050  1.217  
Female REF REF REF REF 
AGE     
13 0.326 ** 0.519 ** 0.194** 0.717  
14 0.136 ** 0.694  0.257 ** 0.676  
15 0.474  0.683  0.424 ** 0.801  
16 0.513  0.995  0.686  0.931  
17 REF REF REF REF 
RACE AND ETHNICITY     
Non-Hispanic White REF REF REF REF 
Non-Hispanic Black or African 
American 1.246  0.895  0.563  0.514  
Hispanic or Latino 0.9  1.036  1.754  0.952  
Non-Hispanic Other & Multiple 
Race 0.758  0.532 ** 1.016  0.657  
POVERTY STATUS     
Below Poverty Level 1.207  1.032  0.815  0.754  
At Or Above Poverty Level REF REF REF REF 
MOTHER'S EDUCATION 
STATUS     
Less Than High School 3.332 ** 178 ** 1.832 ** 1.383  
High School 4.32 ** 1.626 ** 2.377 ** 1.279  
> High School, College Non-Grad 3.525 ** 1.113  2.306 ** 1.489  
College Graduate REF REF REF REF 
MOTHER'S MARITAL STATUS     
Married REF REF REF REF 
Never 
M/Dive/Widow/Separate/Decease 2.256  1.167  1.134  0.896  
MOTHER'S AGE GROUP     
≤34 years 1.756  0.969  1.063  0.879   
35-44 years 1.206  1.436  1.335  1.414   
≥45 years REF REF REF REF 
STATES     
 NH REF NH REF WI REF WI REF 
 CT 0.364  CT 1.243  IL 1.829  IL 5.161 ** 
 MA 3.72 ** MA 2.969 ** ID 0.780 ** ID 1.074  
 MD 1.147  MD 1.63  IW 4.885 ** IW 8.19 ** 
 NJ 3.192  NJ 3.06 ** KS 3.086  KS 5.697 ** 
 NY 3.742  NY 3.364 ** MI 0.673  MI 2.001 ** 
 PA 1.281  PA 1.156  MN 1.107  MN 1.716  
 RI 2.824  RI 1.354  MI 5.531 ** MI 8.331 ** 
 VA 5.556 ** VA 1.048  NB 1.121  NB 2.778 ** 
     ND 4.415 ** ND 4.569 ** 
     OH 2.23  OH 5.446 ** 
     SD 
7.857 ** 
SD 
15.29 ** 
** Odds ratios are significant at P-value < 0.05 
Table 3.3 Weighted Estimates of Odds Ratios of Vaccination Status for Participants Aged  
13 – 17 Years in the United States (NORTHEAST & MIDWEST) 
NIS-TEEN, 2011 
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Table 3.4 Weighted Estimates of Odds Ratios of Vaccination Status for Participants Aged 
13 – 17 Years in the United States (SOUTH & WEST) 
NIS-TEEN, 2011 
 SOUTH REGION WEST REGION 
 0-Dose to 2-Dose 1-Dose to 2-Dose 0-Dose to 2-Dose 1-Dose to 2-Dose 
TOTAL     
GENDER     
Male 0.704  0.741 ** 0.581  0.703 ** 
Female REF REF REF REF 
AGE     
13 0.129 ** 0.519 ** 0.097 ** 0.439 ** 
14 0.159 ** 0.552 ** 0.098 ** 0.490 ** 
15 0.49 ** 0.674 ** 0.371 ** 0.52 ** 
16 0.618  0.833  0.279 ** 0.706  
17 REF REF REF REF 
RACE AND ETHNICITY     
Non-Hispanic White REF REF REF REF 
Non-Hispanic Black or African 
American 0.80  0.556 ** 0.625  0.494 ** 
Hispanic or Latino 0.804  0.83  1.630  0.972  
Non-Hispanic Other & Multiple Race 0.668  0.669  0.550  0.813  
POVERTY STATUS     
Below Poverty Level 0.547  0.827  0.485 ** 0.896  
At Or Above Poverty Level REF REF REF REF 
MOTHER'S EDUCATION STATUS     
Less Than High School 1.136  1.040  1.832 ** 1.336   
High School 1.601  1.325  2.377 ** 1.070   
> High School, College Non-Grad 0.960  0.7 07  2.306 ** 1.315  
College Graduate REF REF REF REF 
MOTHER'S MARITAL STATUS     
Married REF REF REF REF 
Never 
M/Divorce/Widow/Separate/Decease 1.042  1.367  1.134  1.402  
MOTHER'S AGE GROUP     
≤34 years 1.462  0.877  1.063  1.1  
35-44 years 0.757  2.157  1.335  1.0  
≥45 years REF REF REF REF 
STATES     
 DC REF DC REF WO REF WO REF 
 AL 2.523  AL 15.181 ** AL 2.816  AL 2.688  
 AK 3.976 ** AK 21.676 ** AZ 1.398 ** AZ 3.460  
 DE 2.455  DE 3.841 ** CA 3.136 ** CA 1.934  
 FL 1.914  FL 10.413 ** CO 0.874  CO 1.540 ** 
 GA 0.629  GA 3.225 ** HI 0.759  HI 1.834 ** 
 KY 5.409 ** KY 24.073 ** ID 3.022  ID 4.243  
 LA 0.377 ** LA 3.619 ** MO 4.336  MO 2.667  
 MA 1.002  MA 9.844 ** NV 2.427  NV 4.563  
 MI 17.125  ** MI 33.904 ** NM 1.228  NM 2.246  
 NC 6.168  ** NC 8.89 ** OR 0.597  OR 3.02  
 OK 3.219  ** OK 24.704 ** UT 3.101  UT 3.209  
 SC 3.53 ** SC 19.291 ** WA 1.859  WA 1.803  
 TN 2.974  TN 10.814 **     
 TX 3.209 ** TX 6.813 **     
 VA 7.191 ** VA 13.717 **     
 WV 13.48 ** WV 13.514 **     
** Odds ratios are significant at P-value < 0.05 ** Odds ratios are significant at P-value < 0.05 
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Meanwhile, the odds ratios between 15 year olds and 17 year olds are only significant in the 
West and South regions for 1-dose Varicella shots versus 2-dose shots and 0-dose versus 2-dose. 
The only odds ratio significant between 16 year olds compared to 17 years olds is for comparing 
0-dose shot versus 2-dose shots in the West. It implies 16 year olds are over 3.58 times (Odds 
Ratio = 0.279) less likely to obtain a 0-dose as opposed to a 2-dose shot compared to 17 year 
olds in the West region.  
Concerning race, the odds ratios that are significant are between Hispanics compared to Whites 
and between other race/multiple races and whites for 1-dose versus 2-dose shots in the South and 
Northeast regions respectively.  
For income status, the odds ratio significant is between below poverty compared to at or above 
poverty in the West region for 0-dose versus 2-dose Varicella shots.  
Concerning education, the odds ratios are not significant factors in the South and West regions, 
but are significant contributors to some of the levels in the Northeast and Midwest regions.  
For marital status, the odds ratio is significant between never married and married for the 1-dose 
versus 2-dsoe shots in the Northeast region.  
No odds ratios are significant for any category of age groups.  
For individual states, odds ratios are significant between Colorado versus Wyoming, and Hawaii 
versus Wyoming for the 1-dose compared to 2-dose Varicella shots in the West region. Odds 
ratios are also significant between Maine versus New Hampshire for both 0-dose versus 2-dose 
and 1-dose versus 2-dose for the Northeast region, Odds ratio are significant between New 
Jersey versus New Hampshire and New York versus New Hampshire for 0-dose compared to 2-
dose for the Northeast region. Also, odds ratio are significant between Vermont compared to 
New Hampshire for 1-dose versus 2-dose shots in the Northeast region. In the Midwest, odds 
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ratios are significant between Illinois versus Wisconsin, Iowa versus Wisconsin, Kansas versus 
Wisconsin, Michigan versus Wisconsin, Missouri versus Wisconsin, Nebraska versus Wisconsin, 
North Dakota versus Wisconsin, Ohio versus Wisconsin and South Dakota versus Wisconsin for 
0-dose compared 2-dose Varicella shots.  
Again in the Midwest, odds ratios between Indiana versus Wisconsin, Iowa versus Wisconsin, 
Missouri versus Wisconsin, North Dakota versus Wisconsin, and South Dakota versus 
Wisconsin for 1-dose compared to 2-dose Varicella shots were significant. In the South, the odds 
ratio for 1-dose versus 2-dose are significant for all states (Alabama, Arkansas, Delaware, 
Florida, Georgia, Kentucky, Louisiana, Massachusetts, Mississippi, North Carolina, Oklahoma, 
South Carolina, Tennessee, Texas, Virginia, West Virginia)  versus the District of Columbia.  
The odds ratios 0-dose versus 2-dsoe for all the states in the South are all significant versus 
Washington DC except Delaware, Florida, Georgia, Massachusetts, and Tennessee versus 
Washington DC.  
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4 CONCLUSIONS 
From the above study, results obtained for this controlled study for the effectiveness of varicella 
vaccination indicates that gender of the teen, age of the teen, teen mothers’ education level, teen 
mother’s age, race, poverty level, and census region all had significant effects on whether a teen 
will complete the 2-dose Varicella requirement or fall short.  Also, the obtaining the full dose 
was found to be highly effective in preventing the Varicella disease to teens after the nationwide 
implementation of the 2-dose schedule. Also, there is a controversy about whether the optimal 
effectiveness of a full dose of varicella vaccine is due to waning immunity, primary vaccine 
failure or both. However, for the small number of groups for which subjects receive either no 
dose or partial dose or full dose of the vaccine, the study could not provide strong evidence in 
order to assess the effectiveness of partial dose of the vaccine. Therefore, in this study full dose 
of the vaccine was found to be very efficient and after completing the 2-dose requirement there is 
a less chance of disease re-occurring as compared to after partial dose.  
According to the study, when the data was stratified be the 4 Census regions, teens in the West 
(and to some extent in the Midwest) are significantly more likely to be in the 0-dose category 
than Northeast and South regions. Also, age of a teen and the state of residence were significant 
factors in determining your varicella vaccination status. The education level of a teen’s mother 
was an additional significant factor only in the Northeast region. Also, the gender of a teen was 
also an additional significant factor in determining varicella status in the South and Midwest 
regions.  
For future studies, I would recommend comparing the factors impacting Varicella shots for a 
number of different years. Also, the data available in the NIS Public Use File were 
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predominantly categorical measures. I wonder what will happen to the analysis if some 
continuous measures were included such as income amount, age of teen and mother’s age.  
I would also recommend the CDC to concentrate on small geographic areas, find out of what is 
contributing to less than 2-dose varicella vaccinations and come out with strategies to help the 
communities.  
Also, for future studies, someone can look into providing an optimal model either through 
backward or forward or stepwise options coding in SAS.  
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APPENDIX 
SAS  Code  
OPTIONS MLOGIC CENTER NODATE NONUMBER LS=100 PS=80; 
LIBNAME BENDATA "C:\Ben Thesis"; 
OPTIONS FMTSEARCH = (BENDATA); 
 
DATA MYTHESIS; 
 SET BENDATA.NISTEENPUF11(KEEP= PROVWT_D ESTIAPT11 STRATUM_D 
SEQNUMT PDAT VRC_HIST P_NUMVRC SEX AGE AGEGRP_M_I RACEETHK EDUC1 INCPORAR 
MARITAL2  
 CEN_REG STATE); 
 
 WHERE PDAT = 1; 
 
/*HISTORY OF VARICELLA  1 = YES AND 2 = NO*/; 
    IF VRC_HIST = 1  THEN HXVAR = 1;  
    ELSE IF VRC_HIST NE 1 THEN HXVAR = 2; 
 
    MPHXVAR = HXVAR; 
    IF HXVAR = 2 THEN MPHXVAR = 0; 
 
    /*ONE DOSE OF VARICELLA SHOT */; 
    IF P_NUMVRC GE 1 THEN UTDVAR1 = 1; 
    IF P_NUMVRC LT 1 THEN UTDVAR1 = 2; 
 
    MPUTDVAR1 = UTDVAR1; 
    IF UTDVAR1 = 2 THEN MPUTDVAR1 = 0; 
 
    /* TWO DOSES OF VARICELLA SHOT*/; 
    IF P_NUMVRC GE 2 THEN UTDVAR2 = 1; 
    ELSE IF P_NUMVRC LT 2 THEN UTDVAR2 = 2; 
 
    MPUTDVAR2 = UTDVAR2; 
    IF UTDVAR2 = 2 THEN MPUTDVAR2 = 0; 
 
 /*ONE DOSE OF VARICELLA SHOT IN THOSE WITHOUT HISTORY, 
VARNOIMM1=1= SHOT, 2= NO SHOT*/; 
 
    IF HXVAR = 2 AND UTDVAR1 = 1 THEN VARNOIMM1 = 1; 
    ELSE IF HXVAR = 2 AND UTDVAR1 = 2 THEN VARNOIMM1 = 2; 
 
    MPVARNOIMM1 = VARNOIMM1; 
    IF VARNOIMM1 = 2 THEN MPVARNOIMM1 = 0; 
 
 /*TWO DOSES OF VARICELLA SHOT IN THOSE WITHOUT HISTORY, 
VARNOIMM2=1= SHOTS, 2= NO SHOT*/; 
    IF HXVAR = 2 AND UTDVAR2 = 1 THEN VARNOIMM2 = 1; 
    ELSE IF HXVAR = 2 AND UTDVAR2 = 2 THEN VARNOIMM2 = 2; 
 
    MPVARNOIMM2 = VARNOIMM2; 
    IF VARNOIMM2 = 2 THEN MPVARNOIMM2 = 0; 
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 /*ZERO TO TWO DOSES OF VARICELLA SHOT IN THOSE WITHOUT HISTORY, 
NUMVARNOIMM=0,1,2 SHOTS*/; 
    IF HXVAR = 2 AND P_NUMVRC = 0 THEN NUMVARNOIMM = 0; 
    ELSE IF HXVAR = 2 AND P_NUMVRC = 1 THEN NUMVARNOIMM = 1; 
 ELSE IF HXVAR = 2 AND P_NUMVRC = 2 THEN NUMVARNOIMM = 2; 
 
 /*RECODING OF AGE*/ 
    IF AGE = 13 THEN NEWAGE =1; 
    ELSE IF AGE = 14 THEN NEWAGE =2; 
    ELSE IF AGE = 15 THEN NEWAGE =3; 
    ELSE IF AGE = 16 THEN NEWAGE =4; 
    ELSE IF AGE = 17 THEN NEWAGE =5; 
             
    /*1=NON-HISPANIC WHITE, 2=NON-HISPANIC BLACK, 3=HISPANIC, 4=NON-
HISPANIC/OTHER/MULTIPLE RACE*/; 
    IF RACEETHK = 2 THEN NEWRACE = 1; 
    ELSE IF RACEETHK = 3 THEN NEWRACE = 2; 
    ELSE IF RACEETHK = 1 THEN NEWRACE = 3; 
    ELSE IF RACEETHK = 4 THEN NEWRACE = 4; 
     
    /* POVERTY STATUS CALCULATION */ 
    IF INCPORAR = 3 THEN POVSTAT = 1; /* BELOW POVERTY STATUS*/ 
    ELSE IF INCPORAR LT 3 THEN POVSTAT = 2; /*AT OR ABOVE POVERTY 
STATUS*/ 
 
    /*MARITAL STATUS*/ 
    MARITAL=.; 
    IF MARITAL2 = 1 THEN MARITAL=1;/*MARRIED*/ 
    ELSE IF MARITAL2 = 2 THEN MARITAL=2; /*NEVER 
MARRIED/DIVORCED/WIDOWED/SEPARATED/DECEASED*/ 
    
 
    /***** AGE GROUP NEWAGE = 1 IF AGE IS 13 OR 14 OR 15. ******/ 
    NEWAGEGP2 = .; 
    IF AGE IN (13, 14, 15) THEN NEWAGEGP2 = 1; 
    ELSE IF AGE IN (16, 17) THEN NEWAGEGP2 = 2; 
RUN; 
 
PROC FORMAT; 
            VALUE FMTYESNO  1 = 'YES' 
                            2 = 'NO' 
                            ; 
            VALUE FMTAGE      1 = '13' 
                              2 = '14' 
                              3 = '15' 
                              4 = '16' 
                              5 = '17' 
                              ; 
   VALUE FMTAGEG     1 = '13 - 15' 
                              2 = '16 - 17' 
                              ; 
            VALUE FMTRACETH   1 = 'NON-HISPANIC WHITE' 
                              2 = 'NON-HISPANIC BLACK OR AFRICAN 
AMERICAN' 
                              3 = 'HISPANIC OR LATINO' 
                              4 = 'NON-HISPANIC OTHER & MULTIPLE RACE' 
                              ; 
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            VALUE FMTPOVSTAT  1 = 'BELOW POVERTY LEVEL' 
                              2 = 'AT OR ABOVE POVERTY LEVEL' 
                              ;              
            VALUE FMTEDUC     1 = 'LESS THAN HIGH SCHOOL' 
                              2 = 'HIGH SCHOOL' 
                              3 = '>HIGH SCHOOL, COLLEGE NON-GRAD' 
                              4 = 'COLLEGE GRADUATE' 
                              ; 
            VALUE FMTMARITAL  1 = 'MARRIED' 
                              2 = 'NEVER 
MARRIED/DIVORCED/WIDOWED/SEPARATED/DECEASED' 
                              ; 
            VALUE FMTMAGE     1 = '<=34 years' 
                              2 = '35-44 years' 
                              3 = '>=45 years' 
                              ; 
            VALUE FMTSEX      1 = 'MALE' 
                              2 = 'FEMALE' 
                              ; 
            VALUE FMTCENREG   1 = 'NORTHEAST' 
                              2 = 'MIDWEST' 
                              3 = 'SOUTH' 
         4 = 'WEST' 
                              ; 
   VALUE STATE  . = "MISSING" 
       1 = "ALABAMA" 
       2 = "ALASKA" 
       3 = " " 
       4 = "ARIZONA" 
       5 = "ARKANSAS" 
       6 = "CALIFORNIA" 
       7 = " " 
       8 = "COLORADO" 
       9 = "CONNECTICUT" 
       10 = "DELAWARE" 
       11 = "DISTRICT OF COLUMBIA" 
       12 = "FLORIDA" 
       13 = "GEORGIA" 
       14 = " " 
       15 = "HAWAII" 
       16 = "IDAHO" 
       17 = "ILLINOIS" 
       18 = "INDIANA" 
       19 = "IOWA" 
       20 = "KANSAS" 
       21 = "KENTUCKY" 
       22 = "LOUISIANA" 
       23 = "MAINE" 
       24 = "MARYLAND" 
       25 = "MASSACHUSETTS" 
       26 = "MICHIGAN" 
       27 = "MINNESOTA" 
       28 = "MISSISSIPPI" 
       29 = "MISSOURI" 
       30 = "MONTANA" 
       31 = "NEBRASKA" 
       32 = "NEVADA" 
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       33 = "NEW HAMPSHIRE" 
       34 = "NEW JERSEY" 
       35 = "NEW MEXICO" 
       36 = "NEW YORK" 
       37 = "NORTH CAROLINA" 
       38 = "NORTH DAKOTA" 
       39 = "OHIO" 
       40 = "OKLAHOMA" 
       41 = "OREGON" 
       42 = "PENNSYLVANIA" 
       43 = " " 
       44 = "RHODE ISLAND" 
       45 = "SOUTH CAROLINA" 
       46 = "SOUTH DAKOTA" 
       47 = "TENNESSEE" 
       48 = "TEXAS" 
       49 = "UTAH" 
       50 = "VERMONT" 
       51 = "VIRGINIA" 
       52 = " " 
       53 = "WASHINGTON" 
       54 = "WEST VIRGINIA" 
       55 = "WISCONSIN" 
       56 = "WYOMING" 
       78 = "U.S. VIRGIN ISLANDS" 
       ; 
   VALUE FLGYESNO  1 = 'YES' 
                            0 = 'NO' 
                            ; 
   VALUE VACNUM    0 = 'ZERO DOSE' 
                            1 = 'ONE DOSE' 
       2 = 'TWO DOSES' 
                            ; 
RUN; 
 
PROC SORT DATA = MYTHESIS; 
 BY STRATUM_D SEQNUMT; 
RUN; 
 
%MACRO VARDOSES(VAR1, VAR2, DESCRIPTION); 
ods html body="C:\Ben  
Thesis\NEWTWODOSESOUTPUT\Table1\Table1FreqALL&VAR1..xls"; 
  
/*** DEMONSTRATE THE SURVEYFREQ PROCEDURE ***/ 
TITLE1 "FREQUENCY ANALYSIS – NATIONAL NIS2011"; 
TITLE2 'UNIVARIATE FREQUENCIES ON VARIOUS VARIABLES'; 
TITLE3 "TEEN AGES"; 
PROC SURVEYFREQ DATA = MYTHESIS; 
        STRATA  STRATUM_D; 
        CLUSTER SEQNUMT; 
        WEIGHT  PROVWT_D; 
        TABLES  &VAR1/ROW CL NOWT; 
        FORMAT &VAR1 &VAR2; 
RUN; 
 
%MEND VARDOSES; 
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%VARDOSES(VARNOIMM1,FMTYESNO.,"1+ UTD VARICELLA"); 
%VARDOSES(VARNOIMM2,FMTYESNO.,"2+ UTD VARICELLA"); 
%VARDOSES(NUMVARNOIMM,VACNUM.,"NUMBER OF DOSES OF VARICELLA"); 
%VARDOSES(SEX, FMTSEX.,"GENDER"); 
%VARDOSES(NEWAGE, FMTAGE.,"AGE"); 
%VARDOSES(NEWRACE, FMTRACETH.,"RACE"); 
%VARDOSES(POVSTAT, FMTPOVSTAT.,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, FMTEDUC.,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, FMTMARITAL.,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, FMTMAGE.,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, FMTCENREG.,"CENSUS REGION"); 
%VARDOSES(STATE, STATE.,"STATE"); 
 
 
***********************************************************************
********** 
THIS PROGRAM WILL PRODUCE ESTIMATES AND STANDARD ERRORS FOR VARICERLLA 
USING SAS. 
***********************************************************************
**********; 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, VAR4, DESCRIPTION); 
PROC SORT DATA = MYTHESIS; 
 BY &VAR2; 
RUN; 
  
ODS OUTPUT STATISTICS=SAS_EST; 
 
PROC SURVEYMEANS DATA = MYTHESIS NOBS SUM MEAN STDERR; 
 STRATUM STRATUM_D; 
 CLUSTER SEQNUMT; 
 WEIGHT PROVWT_D; 
 CLASS &VAR1; 
 VAR &VAR1; 
 BY &VAR2; 
 FORMAT &VAR1 &VAR4; 
 FORMAT &VAR2 &VAR3; 
RUN; 
 
DATA SAS_EST1; 
 LENGTH M&VAR2 $30.; 
 SET SAS_EST; 
 MEAN = MEAN*100; *CONVERT TO PERCENT ESTIMATES; 
 STDERR = STDERR*100; 
  
 M&VAR2 = PUT(&VAR2, &VAR3); 
  
 KEEP M&VAR2 VARLEVEL N SUM MEAN STDERR; 
 FORMAT MEAN STDERR 5.2; 
RUN; 
 
PROC EXPORT DATA=SAS_EST1 OUTFILE="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table6\MyCoverage&VAR1&VAR2..xls" 
 DBMS=EXCELCS REPLACE; 
RUN; 
 
%MEND VARDOSES; 
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%VARDOSES(VARNOIMM1,SEX, FMTSEX., FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM1,NEWAGE, FMTAGE., FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM1,NEWRACE, FMTRACETH., FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM1,POVSTAT, FMTPOVSTAT., FMTYESNO.,"PROVERTY STATUS"); 
%VARDOSES(VARNOIMM1,EDUC1, FMTEDUC., FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM1,MARITAL, FMTMARITAL., FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM1,AGEGRP_M_I, FMTMAGE., FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM1,CEN_REG, FMTCENREG., FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM1,STATE, STATE., FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM2,SEX, FMTSEX., FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM2,NEWAGE, FMTAGE., FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM2,NEWRACE, FMTRACETH., FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM2,POVSTAT, FMTPOVSTAT., FMTYESNO.,"PROVERTY STATUS"); 
%VARDOSES(VARNOIMM2,EDUC1, FMTEDUC., FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM2,MARITAL, FMTMARITAL., FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM2,AGEGRP_M_I, FMTMAGE., FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM2,CEN_REG, FMTCENREG., FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM2,STATE, STATE., FMTYESNO.,"STATE"); 
 
%VARDOSES(NUMVARNOIMM,SEX, FMTSEX.,VACNUM.,"GENDER"); 
%VARDOSES(NUMVARNOIMM,NEWAGE, FMTAGE.,VACNUM.,"AGE"); 
%VARDOSES(NUMVARNOIMM,NEWRACE, FMTRACETH.,VACNUM.,"RACE"); 
%VARDOSES(NUMVARNOIMM,POVSTAT, FMTPOVSTAT.,VACNUM.,"PROVERTY STATUS"); 
%VARDOSES(NUMVARNOIMM,EDUC1, FMTEDUC.,VACNUM.,"MOTHER'S EDUCATION"); 
%VARDOSES(NUMVARNOIMM,MARITAL, FMTMARITAL.,VACNUM.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(NUMVARNOIMM,AGEGRP_M_I, FMTMAGE.,VACNUM.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(NUMVARNOIMM,CEN_REG, FMTCENREG., VACNUM.,"CENSUS REGION"); 
%VARDOSES(NUMVARNOIMM,STATE, STATE., VACNUM.,"STATE"); 
 
/********************************************************/ 
/***** LOGISTIC REGRESSION USING REFLEVEL STATEMENT *****/ 
/********************************************************/ 
PROC SORT DATA = MYTHESIS; 
 BY STRATUM_D SEQNUMT; 
RUN; 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table2\UnAdjusted1DOSE&VAR1..xls";  
TITLE2 '1+VARICELLA DOSES BY DEMOGRAPHICS: CATEGORICAL VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS   &VAR2; 
  MODEL MPVARNOIMM1(DESCENDING) =  &VAR1; 
/* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1*/ 
  FORMAT MPVARNOIMM1 FLGYESNO.; 
  FORMAT &VAR1  &VAR3; 
32 
RUN; 
%MEND VARDOSES; 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, CEN_REG(PARAM=REF REF='NORTHEAST'),FMTCENREG., 
"CENSUS REGION"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='CONNECTICUT'), STATE.,"STATE"); 
 
 
ODS HTML BODY='C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table3\Adjusted1DOSEVARICELLA.xls';  
 
TITLE2 '1+ VARICELLA DOSES BY DEMOGRAPHICS ADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS SEX(PARAM=REF REF='FEMALE') NEWAGE(PARAM=REF 
REF='17') NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE') POVSTAT(PARAM=REF 
REF='AT OR ABOVE POVERTY LEVEL')  
     EDUC1(PARAM=REF REF='COLLEGE GRADUATE') 
MARITAL(PARAM=REF REF='MARRIED') AGEGRP_M_I(PARAM=REF REF='>=45 years')  
     CEN_REG(PARAM=REF REF='NORTHEAST') STATE(PARAM=REF 
REF='CONNECTICUT'); 
  MODEL MPVARNOIMM1(DESCENDING) = SEX NEWAGE NEWRACE POVSTAT 
EDUC1 MARITAL AGEGRP_M_I CEN_REG STATE; 
/* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1 */ 
  FORMAT MPVARNOIMM1 FLGYESNO. SEX FMTSEX. NEWAGE FMTAGE. 
NEWRACE FMTRACETH. POVSTAT FMTPOVSTAT. EDUC1 FMTEDUC.  
      MARITAL FMTMARITAL. AGEGRP_M_I FMTMAGE. 
CEN_REG FMTCENREG. STATE STATE.; 
RUN; 
 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table2\UnAdjusted2DOSES&VAR1..xls";  
TITLE2 '2+ VARICELLA DOSES BY DEMOGRAPHICS UNADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS   &VAR2; 
  MODEL MPVARNOIMM2(DESCENDING) =  &VAR1; 
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 /* DESCENDING TO MODEL PROBABILITY OF 2+ DOSES OF VARICELLA = 1*/ 
  FORMAT MPVARNOIMM2 FLGYESNO.; 
  FORMAT &VAR1  &VAR3; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, CEN_REG(PARAM=REF REF='NORTHEAST'),FMTCENREG., 
"CENSUS REGION"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='DISTRICT OF COLUMBIA'), 
STATE.,"STATE"); 
 
 
ODS HTML BODY='C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table3\Adjusted2DOSESVARICELLA.xls'; 
  
TITLE2 '2+ VARICELLA DOSES BY DEMOGRAPHICS ADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS SEX(PARAM=REF REF='FEMALE') NEWAGE(PARAM=REF 
REF='17') NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE') POVSTAT(PARAM=REF 
REF='AT OR ABOVE POVERTY LEVEL')  
     EDUC1(PARAM=REF REF='COLLEGE GRADUATE') 
MARITAL(PARAM=REF REF='MARRIED') AGEGRP_M_I(PARAM=REF REF='>=45 years')  
     CEN_REG(PARAM=REF REF='NORTHEAST') STATE(PARAM=REF 
REF='DISTRICT OF COLUMBIA'); 
  MODEL MPVARNOIMM2(DESCENDING) = SEX NEWAGE NEWRACE POVSTAT 
EDUC1 MARITAL AGEGRP_M_I CEN_REG STATE; 
 /* DESCENDING TO MODEL PROBABILITY OF 2+ DOSES OF VARICELLA = 1*/ 
  FORMAT MPVARNOIMM2 FLGYESNO. SEX FMTSEX. NEWAGE FMTAGE. 
NEWRACE FMTRACETH. POVSTAT FMTPOVSTAT. EDUC1 FMTEDUC.  
      MARITAL FMTMARITAL. AGEGRP_M_I FMTMAGE. 
CEN_REG FMTCENREG. STATE STATE.; 
RUN; 
 
ODS HTML CLOSE; 
 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, DESCRIPTION); 
ods html body="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table2\UnAdjustedALLDOSES&VAR1..xls";  
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TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS UNADJUSTED: 
CATEGORICAL VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS   &VAR2; 
  MODEL NUMVARNOIMM(REF='TWO DOSES') =  &VAR1 / LINK=GLOGIT; 
 /* DESCENDING TO MODEL PROBABILITY OF 2+ DOSES OF VARICELLA = 1*/ 
  FORMAT NUMVARNOIMM VACNUM.; 
  FORMAT &VAR1  &VAR3; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, CEN_REG(PARAM=REF REF='NORTHEAST'),FMTCENREG., 
"CENSUS REGION"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='DISTRICT OF COLUMBIA'), 
STATE.,"STATE"); 
 
 
ODS HTML BODY='C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table3\AdjustedALLDOSESVARICELLA.xls'; 
  
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS ADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS SEX(PARAM=REF REF='FEMALE') NEWAGE(PARAM=REF 
REF='17') NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE') POVSTAT(PARAM=REF 
REF='AT OR ABOVE POVERTY LEVEL')  
     EDUC1(PARAM=REF REF='COLLEGE GRADUATE') 
MARITAL(PARAM=REF REF='MARRIED') AGEGRP_M_I(PARAM=REF REF='>=45 years')  
     CEN_REG(PARAM=REF REF='NORTHEAST') STATE(PARAM=REF 
REF='DISTRICT OF COLUMBIA'); 
  MODEL NUMVARNOIMM(REF='TWO DOSES') = SEX NEWAGE NEWRACE 
POVSTAT EDUC1 MARITAL AGEGRP_M_I CEN_REG STATE/ LINK=GLOGIT; 
 /* DESCENDING TO MODEL PROBABILITY OF 2+ DOSES OF VARICELLA = 1*/ 
  FORMAT NUMVARNOIMM VACNUM. SEX FMTSEX. NEWAGE FMTAGE. 
NEWRACE FMTRACETH. POVSTAT FMTPOVSTAT. EDUC1 FMTEDUC.  
      MARITAL FMTMARITAL. AGEGRP_M_I FMTMAGE. 
CEN_REG FMTCENREG. STATE STATE.; 
RUN; 
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ODS HTML CLOSE; 
 
/******************************************************************/ 
/************ STRATIFYING BY U.S. CENSUS REGION *******************/ 
/******************************************************************/ 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\FREQCENREG&VAR3&VAR1..xls"; 
  
/* DEMONSTRATE THE SURVEYFREQ PROCEDURE */ 
TITLE1 "FREQUENCY ANALYSIS – NATIONAL NIS2011"; 
TITLE2 'UNIVARIATE FREQUENCIES ON VARIOUS VARIABLES'; 
TITLE3 "TEEN AGES"; 
PROC SURVEYFREQ DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR3; 
        STRATA  STRATUM_D; 
        CLUSTER SEQNUMT; 
        WEIGHT  PROVWT_D; 
        TABLES  &VAR1/ROW CL NOWT; 
        FORMAT &VAR1 &VAR2; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(VARNOIMM1,FMTYESNO.,1,"1+ UTD VARICELLA"); 
%VARDOSES(VARNOIMM2,FMTYESNO.,1,"2+ UTD VARICELLA"); 
%VARDOSES(NUMVARNOIMM,VACNUM.,1,"NUMBER OF DOSES OF VARICELLA"); 
%VARDOSES(SEX, FMTSEX.,1,"GENDER"); 
%VARDOSES(NEWAGE, FMTAGE.,1,"AGE"); 
%VARDOSES(NEWRACE, FMTRACETH.,1,"RACE"); 
%VARDOSES(POVSTAT, FMTPOVSTAT.,1,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, FMTEDUC.,1,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, FMTMARITAL.,1,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, FMTMAGE.,1,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, FMTCENREG.,1,"CENSUS REGION"); 
%VARDOSES(STATE, STATE.,1,"STATE"); 
 
%VARDOSES(VARNOIMM1,FMTYESNO.,2,"1+ UTD VARICELLA"); 
%VARDOSES(VARNOIMM2,FMTYESNO.,2,"2+ UTD VARICELLA"); 
%VARDOSES(NUMVARNOIMM,VACNUM.,2,"NUMBER OF DOSES OF VARICELLA"); 
%VARDOSES(SEX, FMTSEX.,2,"GENDER"); 
%VARDOSES(NEWAGE, FMTAGE.,2,"AGE"); 
%VARDOSES(NEWRACE, FMTRACETH.,2,"RACE"); 
%VARDOSES(POVSTAT, FMTPOVSTAT.,2,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, FMTEDUC.,2,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, FMTMARITAL.,2,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, FMTMAGE.,2,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, FMTCENREG.,2,"CENSUS REGION"); 
%VARDOSES(STATE, STATE.,2,"STATE"); 
 
%VARDOSES(VARNOIMM1,FMTYESNO.,3,"1+ UTD VARICELLA"); 
%VARDOSES(VARNOIMM2,FMTYESNO.,3,"2+ UTD VARICELLA"); 
%VARDOSES(NUMVARNOIMM,VACNUM.,3,"NUMBER OF DOSES OF VARICELLA"); 
%VARDOSES(SEX, FMTSEX.,3,"GENDER"); 
%VARDOSES(NEWAGE, FMTAGE.,3,"AGE"); 
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%VARDOSES(NEWRACE, FMTRACETH.,3,"RACE"); 
%VARDOSES(POVSTAT, FMTPOVSTAT.,3,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, FMTEDUC.,3,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, FMTMARITAL.,3,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, FMTMAGE.,3,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, FMTCENREG.,3,"CENSUS REGION"); 
%VARDOSES(STATE, STATE.,3,"STATE"); 
 
%VARDOSES(VARNOIMM1,FMTYESNO.,4,"1+ UTD VARICELLA"); 
%VARDOSES(VARNOIMM2,FMTYESNO.,4,"2+ UTD VARICELLA"); 
%VARDOSES(NUMVARNOIMM,VACNUM.,4,"NUMBER OF DOSES OF VARICELLA"); 
%VARDOSES(SEX, FMTSEX.,4,"GENDER"); 
%VARDOSES(NEWAGE, FMTAGE.,4,"AGE"); 
%VARDOSES(NEWRACE, FMTRACETH.,4,"RACE"); 
%VARDOSES(POVSTAT, FMTPOVSTAT.,4,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, FMTEDUC.,4,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, FMTMARITAL.,4,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, FMTMAGE.,4,"MOTHER'S AGE GROUP"); 
%VARDOSES(CEN_REG, FMTCENREG.,4,"CENSUS REGION"); 
%VARDOSES(STATE, STATE.,4,"STATE"); 
 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, VAR4, VAR5, DESCRIPTION); 
PROC SORT DATA = MYTHESIS; 
 BY &VAR2; 
RUN; 
 
ODS OUTPUT STATISTICS=SAS_EST; 
 
PROC SURVEYMEANS DATA = MYTHESIS NOBS SUM MEAN STDERR; 
 WHERE CEN_REG = &VAR4; 
 STRATUM STRATUM_D; 
 CLUSTER SEQNUMT; 
 WEIGHT PROVWT_D; 
 CLASS &VAR1; 
 VAR &VAR1; 
 BY &VAR2; 
 FORMAT &VAR1 &VAR5; 
 FORMAT &VAR2 &VAR3; 
RUN; 
 
DATA SAS_EST1; 
 LENGTH M&VAR2 $30.; 
 SET SAS_EST; 
 MEAN = MEAN*100; *CONVERT TO PERCENT ESTIMATES; 
 STDERR = STDERR*100; 
  
 M&VAR2 = PUT(&VAR2, &VAR3); 
  
 KEEP M&VAR2 VARLEVEL N SUM MEAN STDERR; 
 FORMAT MEAN STDERR 5.2; 
RUN; 
 
PROC EXPORT DATA=SAS_EST1 OUTFILE="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\MyCoverageCENREG&VAR4&VAR1&VAR2..xls" 
 DBMS=EXCELCS REPLACE; 
RUN; 
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%MEND VARDOSES; 
 
%VARDOSES(VARNOIMM1,SEX, FMTSEX.,1,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM1,NEWAGE, FMTAGE.,1,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM1,NEWRACE, FMTRACETH.,1,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM1,POVSTAT, FMTPOVSTAT.,1,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM1,EDUC1, FMTEDUC.,1,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM1,MARITAL, FMTMARITAL.,1,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM1,AGEGRP_M_I, FMTMAGE.,1,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM1,CEN_REG, FMTCENREG.,1,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM1,STATE, STATE.,1,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM1,SEX, FMTSEX.,2,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM1,NEWAGE, FMTAGE.,2,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM1,NEWRACE, FMTRACETH.,2,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM1,POVSTAT, FMTPOVSTAT.,2,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM1,EDUC1, FMTEDUC.,2,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM1,MARITAL, FMTMARITAL.,2,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM1,AGEGRP_M_I, FMTMAGE.,2,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM1,CEN_REG, FMTCENREG.,2,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM1,STATE, STATE.,2,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM1,SEX, FMTSEX.,3,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM1,NEWAGE, FMTAGE.,3,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM1,NEWRACE, FMTRACETH.,3,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM1,POVSTAT, FMTPOVSTAT.,3,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM1,EDUC1, FMTEDUC.,3, FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM1,MARITAL, FMTMARITAL.,3,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM1,AGEGRP_M_I, FMTMAGE.,3,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM1,CEN_REG, FMTCENREG.,3,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM1,STATE, STATE.,3,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM1,SEX, FMTSEX.,4,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM1,NEWAGE, FMTAGE.,4,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM1,NEWRACE, FMTRACETH.,4,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM1,POVSTAT, FMTPOVSTAT.,4,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM1,EDUC1, FMTEDUC., 4,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM1,MARITAL, FMTMARITAL.,4,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM1,AGEGRP_M_I, FMTMAGE.,4,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM1,CEN_REG, FMTCENREG.,4,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM1,STATE, STATE.,4,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM2,SEX, FMTSEX.,1,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM2,NEWAGE, FMTAGE.,1,FMTYESNO.,"AGE"); 
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%VARDOSES(VARNOIMM2,NEWRACE, FMTRACETH.,1,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM2,POVSTAT, FMTPOVSTAT.,1,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM2,EDUC1, FMTEDUC.,1,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM2,MARITAL, FMTMARITAL.,1,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM2,AGEGRP_M_I, FMTMAGE.,1,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM2,CEN_REG, FMTCENREG.,1,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM2,STATE, STATE.,1,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM2,SEX, FMTSEX.,2,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM2,NEWAGE, FMTAGE.,2,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM2,NEWRACE, FMTRACETH.,2,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM2,POVSTAT, FMTPOVSTAT.,2,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM2,EDUC1, FMTEDUC.,2,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM2,MARITAL, FMTMARITAL.,2,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM2,AGEGRP_M_I, FMTMAGE.,2,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM2,CEN_REG, FMTCENREG.,2,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM2,STATE, STATE.,2,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM2,SEX, FMTSEX.,3,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM2,NEWAGE, FMTAGE.,3,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM2,NEWRACE, FMTRACETH.,3,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM2,POVSTAT, FMTPOVSTAT.,3,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM2,EDUC1, FMTEDUC.,3,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM2,MARITAL, FMTMARITAL.,3,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM2,AGEGRP_M_I, FMTMAGE.,3,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM2,CEN_REG, FMTCENREG.,3,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM2,STATE, STATE.,3,FMTYESNO.,"STATE"); 
 
%VARDOSES(VARNOIMM2,SEX, FMTSEX.,4,FMTYESNO.,"GENDER"); 
%VARDOSES(VARNOIMM2,NEWAGE, FMTAGE.,4,FMTYESNO.,"AGE"); 
%VARDOSES(VARNOIMM2,NEWRACE, FMTRACETH.,4,FMTYESNO.,"RACE"); 
%VARDOSES(VARNOIMM2,POVSTAT, FMTPOVSTAT.,4,FMTYESNO.,"PROVERTY 
STATUS"); 
%VARDOSES(VARNOIMM2,EDUC1, FMTEDUC.,4,FMTYESNO.,"MOTHER'S EDUCATION"); 
%VARDOSES(VARNOIMM2,MARITAL, FMTMARITAL.,4,FMTYESNO.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(VARNOIMM2,AGEGRP_M_I, FMTMAGE.,4,FMTYESNO.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(VARNOIMM2,CEN_REG, FMTCENREG.,4,FMTYESNO.,"CENSUS REGION"); 
%VARDOSES(VARNOIMM2,STATE, STATE.,4,FMTYESNO.,"STATE"); 
 
%VARDOSES(NUMVARNOIMM,SEX, FMTSEX.,1,VACNUM.,"GENDER"); 
%VARDOSES(NUMVARNOIMM,NEWAGE, FMTAGE.,1,VACNUM.,"AGE"); 
%VARDOSES(NUMVARNOIMM,NEWRACE, FMTRACETH.,1,VACNUM.,"RACE"); 
%VARDOSES(NUMVARNOIMM,POVSTAT, FMTPOVSTAT.,1,VACNUM.,"PROVERTY 
STATUS"); 
%VARDOSES(NUMVARNOIMM,EDUC1, FMTEDUC.,1,VACNUM.,"MOTHER'S EDUCATION"); 
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%VARDOSES(NUMVARNOIMM,MARITAL, FMTMARITAL.,1,VACNUM.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(NUMVARNOIMM,AGEGRP_M_I, FMTMAGE.,1,VACNUM.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(NUMVARNOIMM,STATE, STATE.,1,VACNUM.,"STATES IN THE U.S.A."); 
 
%VARDOSES(NUMVARNOIMM,SEX, FMTSEX.,2,VACNUM.,"GENDER"); 
%VARDOSES(NUMVARNOIMM,NEWAGE, FMTAGE.,2,VACNUM.,"AGE"); 
%VARDOSES(NUMVARNOIMM,NEWRACE, FMTRACETH.,2,VACNUM.,"RACE"); 
%VARDOSES(NUMVARNOIMM,POVSTAT, FMTPOVSTAT.,2,VACNUM.,"PROVERTY 
STATUS"); 
%VARDOSES(NUMVARNOIMM,EDUC1, FMTEDUC.,2,VACNUM.,"MOTHER'S EDUCATION"); 
%VARDOSES(NUMVARNOIMM,MARITAL, FMTMARITAL.,2,VACNUM.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(NUMVARNOIMM,AGEGRP_M_I, FMTMAGE.,2,VACNUM.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(NUMVARNOIMM,STATE, STATE.,2,VACNUM.,"STATES IN THE U.S.A."); 
 
%VARDOSES(NUMVARNOIMM,SEX, FMTSEX.,3,VACNUM.,"GENDER"); 
%VARDOSES(NUMVARNOIMM,NEWAGE, FMTAGE.,3,VACNUM.,"AGE"); 
%VARDOSES(NUMVARNOIMM,NEWRACE, FMTRACETH.,3,VACNUM.,"RACE"); 
%VARDOSES(NUMVARNOIMM,POVSTAT, FMTPOVSTAT.,3,VACNUM.,"PROVERTY 
STATUS"); 
%VARDOSES(NUMVARNOIMM,EDUC1, FMTEDUC.,3,VACNUM.,"MOTHER'S EDUCATION"); 
%VARDOSES(NUMVARNOIMM,MARITAL, FMTMARITAL.,3,VACNUM.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(NUMVARNOIMM,AGEGRP_M_I, FMTMAGE.,3,VACNUM.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(NUMVARNOIMM,STATE, STATE.,3,VACNUM.,"STATES IN THE U.S.A."); 
 
%VARDOSES(NUMVARNOIMM,SEX, FMTSEX.,4,VACNUM.,"GENDER"); 
%VARDOSES(NUMVARNOIMM,NEWAGE, FMTAGE.,4,VACNUM.,"AGE"); 
%VARDOSES(NUMVARNOIMM,NEWRACE, FMTRACETH.,4,VACNUM.,"RACE"); 
%VARDOSES(NUMVARNOIMM,POVSTAT, FMTPOVSTAT.,4,VACNUM.,"PROVERTY 
STATUS"); 
%VARDOSES(NUMVARNOIMM,EDUC1, FMTEDUC.,4,VACNUM.,"MOTHER'S EDUCATION"); 
%VARDOSES(NUMVARNOIMM,MARITAL, FMTMARITAL.,4,VACNUM.,"MOTHER'S MARITAL 
STATUS"); 
%VARDOSES(NUMVARNOIMM,AGEGRP_M_I, FMTMAGE.,4,VACNUM.,"MOTHER'S AGE 
GROUP"); 
%VARDOSES(NUMVARNOIMM,STATE, STATE.,4,VACNUM.,"STATES IN THE U.S.A."); 
 
PROC SORT DATA = MYTHESIS; 
 BY STRATUM_D SEQNUMT; 
RUN; 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, VAR4, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\UnAdjVARNOIMM1CENREG&VAR4&VAR1..xls";  
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR4; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS   &VAR2; 
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  MODEL MPVARNOIMM1(DESCENDING) =  &VAR1; 
 /* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1*/ 
  FORMAT MPVARNOIMM1 FLGYESNO.; 
  FORMAT &VAR1  &VAR3; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,1,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,1,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,1,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,1,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,1,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,1,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,1,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='CONNECTICUT'), STATE.,1,"MOTHER'S 
AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,2,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,2,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,2,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,2,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,2,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,2,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,2,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='MICHIGAN'), STATE.,2,"MOTHER'S 
AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,3,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,3,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,3,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,3,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,3,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,3,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,3,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='LOUISIANA'), STATE.,3,"MOTHER'S 
AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,4,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,4,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,4,"RACE"); 
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%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,4,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,4,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,4,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,4,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='OREGON'), STATE.,4,"MOTHER'S AGE 
GROUP"); 
 
 
%MACRO VARDOSES(VAR1, VAR2, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\AdjVARNOIMM1CENREG&VAR1..xls";  
 
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS ADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR1; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS SEX(PARAM=REF REF='FEMALE') NEWAGE(PARAM=REF 
REF='17') NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE') POVSTAT(PARAM=REF 
REF='AT OR ABOVE POVERTY LEVEL')  
     EDUC1(PARAM=REF REF='COLLEGE GRADUATE') 
MARITAL(PARAM=REF REF='MARRIED') AGEGRP_M_I(PARAM=REF REF='>=45 years') 
&VAR2; 
  MODEL MPVARNOIMM1(DESCENDING) = SEX NEWAGE NEWRACE POVSTAT 
EDUC1 MARITAL AGEGRP_M_I STATE; 
/* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1 */ 
  FORMAT MPVARNOIMM1 FLGYESNO. SEX FMTSEX. NEWAGE FMTAGE. 
NEWRACE FMTRACETH. POVSTAT FMTPOVSTAT. EDUC1 FMTEDUC. MARITAL FMTMARITAL. 
AGEGRP_M_I FMTMAGE. 
   STATE STATE.; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(1, STATE(PARAM=REF REF='CONNECTICUT'), "STATE OF RESIDENCE"); 
%VARDOSES(2, STATE(PARAM=REF REF='MICHIGAN'), "STATE OF RESIDENCE"); 
%VARDOSES(3, STATE(PARAM=REF REF='LOUISIANA'), "STATE OF RESIDENCE"); 
%VARDOSES(4, STATE(PARAM=REF REF='OREGON'), "STATE OF RESIDENCE"); 
 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, VAR4, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\UnAdjVARNOIMM2CENREG&VAR4&VAR1..xls";  
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR4; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS   &VAR2; 
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  MODEL MPVARNOIMM2(DESCENDING) =  &VAR1; 
 /* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1*/ 
  FORMAT MPVARNOIMM2 FLGYESNO.; 
  FORMAT &VAR1  &VAR3; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,1,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,1,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,1,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,1,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,1,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,1,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,1,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='NEW HAMPSHIRE'), 
STATE.,1,"MOTHER'S AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,2,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,2,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,2,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,2,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,2,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,2,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,2,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='WISCONSIN'), STATE.,2,"MOTHER'S 
AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,3,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,3,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,3,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,3,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,3,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,3,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,3,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='DISTRICT OF COLUMBIA'), 
STATE.,3,"MOTHER'S AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,4,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,4,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,4,"RACE"); 
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%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,4,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,4,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,4,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,4,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='WYOMING'), STATE.,4,"MOTHER'S AGE 
GROUP"); 
 
 
%MACRO VARDOSES(VAR1, VAR2, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\AdjVARNOIMM2CENREG&VAR1..xls";  
 
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS ADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR1; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS SEX(PARAM=REF REF='FEMALE') NEWAGE(PARAM=REF 
REF='17') NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE') POVSTAT(PARAM=REF 
REF='AT OR ABOVE POVERTY LEVEL')  
     EDUC1(PARAM=REF REF='COLLEGE GRADUATE') 
MARITAL(PARAM=REF REF='MARRIED') AGEGRP_M_I(PARAM=REF REF='>=45 years') 
&VAR2; 
  MODEL MPVARNOIMM2(DESCENDING) = SEX NEWAGE NEWRACE POVSTAT 
EDUC1 MARITAL AGEGRP_M_I STATE; 
/* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1 */ 
  FORMAT MPVARNOIMM2 FLGYESNO. SEX FMTSEX. NEWAGE FMTAGE. 
NEWRACE FMTRACETH. POVSTAT FMTPOVSTAT. EDUC1 FMTEDUC. MARITAL FMTMARITAL. 
AGEGRP_M_I FMTMAGE. 
   STATE STATE.; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(1, STATE(PARAM=REF REF='NEW HAMPSHIRE'), "STATE OF 
RESIDENCE"); 
%VARDOSES(2, STATE(PARAM=REF REF='WISCONSIN'), "STATE OF RESIDENCE"); 
%VARDOSES(3, STATE(PARAM=REF REF='DISTRICT OF COLUMBIA'), "STATE OF 
RESIDENCE"); 
%VARDOSES(4, STATE(PARAM=REF REF='WYOMING'), "STATE OF RESIDENCE"); 
 
 
 
%MACRO VARDOSES(VAR1, VAR2, VAR3, VAR4, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\UnAdjVARNOIMMCENREG&VAR4&VAR1..xls";  
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR4; 
  STRATA STRATUM_D; 
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  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS   &VAR2; 
  MODEL NUMVARNOIMM(REF='TWO DOSES') =  &VAR1 / LINK=GLOGIT; 
/* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1*/ 
  FORMAT NUMVARNOIMM VACNUM.; 
  FORMAT &VAR1  &VAR3; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,1,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,1,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,1,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,1,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,1,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,1,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,1,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='NEW HAMPSHIRE'), 
STATE.,1,"MOTHER'S AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,2,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,2,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,2,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,2,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,2,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,2,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,2,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='WISCONSIN'), STATE.,2,"MOTHER'S 
AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,3,"GENDER"); 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,3,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,3,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,3,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,3,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,3,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,3,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='DISTRICT OF COLUMBIA'), 
STATE.,3,"MOTHER'S AGE GROUP"); 
 
%VARDOSES(SEX, SEX(PARAM=REF REF='FEMALE'), FMTSEX.,4,"GENDER"); 
45 
%VARDOSES(NEWAGE, NEWAGE(PARAM=REF REF='17'), FMTAGE.,4,"AGE"); 
%VARDOSES(NEWRACE, NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE'), 
FMTRACETH.,4,"RACE"); 
%VARDOSES(POVSTAT, POVSTAT(PARAM=REF REF='AT OR ABOVE POVERTY LEVEL'), 
FMTPOVSTAT.,4,"PROVERTY STATUS"); 
%VARDOSES(EDUC1, EDUC1(PARAM=REF REF='COLLEGE 
GRADUATE'),FMTEDUC.,4,"MOTHER'S EDUCATION"); 
%VARDOSES(MARITAL, MARITAL(PARAM=REF REF='MARRIED'), 
FMTMARITAL.,4,"MOTHER'S MARITAL STATUS"); 
%VARDOSES(AGEGRP_M_I, AGEGRP_M_I(PARAM=REF REF='>=45 years'), 
FMTMAGE.,4,"MOTHER'S AGE GROUP"); 
%VARDOSES(STATE, STATE(PARAM=REF REF='WYOMING'), STATE.,4,"MOTHER'S AGE 
GROUP"); 
 
 
%MACRO VARDOSES(VAR1, VAR2, DESCRIPTION); 
ODS HTML BODY="C:\Ben 
Thesis\NEWTWODOSESOUTPUT\Table4\AdjVARNOIMMCENREG&VAR1..xls";  
 
TITLE2 'NUMBER OF VARICELLA DOSES BY DEMOGRAPHICS ADJUSTED: CATEGORICAL 
VARIABLES'; 
PROC SURVEYLOGISTIC DATA = MYTHESIS; 
  WHERE CEN_REG = &VAR1; 
  STRATA STRATUM_D; 
  CLUSTER SEQNUMT; 
  WEIGHT PROVWT_D; 
  CLASS SEX(PARAM=REF REF='FEMALE') NEWAGE(PARAM=REF 
REF='17') NEWRACE(PARAM=REF REF='NON-HISPANIC WHITE') POVSTAT(PARAM=REF 
REF='AT OR ABOVE POVERTY LEVEL')  
     EDUC1(PARAM=REF REF='COLLEGE GRADUATE') 
MARITAL(PARAM=REF REF='MARRIED') AGEGRP_M_I(PARAM=REF REF='>=45 years') 
&VAR2; 
  MODEL NUMVARNOIMM(REF='TWO DOSES') = SEX NEWAGE NEWRACE 
POVSTAT EDUC1 MARITAL AGEGRP_M_I STATE/ LINK=GLOGIT; 
/* DESCENDING TO MODEL PROBABILITY OF 1+ DOSES OF VARICELLA = 1 */ 
  FORMAT NUMVARNOIMM VACNUM. SEX FMTSEX. NEWAGE FMTAGE. 
NEWRACE FMTRACETH. POVSTAT FMTPOVSTAT. EDUC1 FMTEDUC. MARITAL FMTMARITAL. 
AGEGRP_M_I FMTMAGE. 
   STATE STATE.; 
RUN; 
 
%MEND VARDOSES; 
 
%VARDOSES(1, STATE(PARAM=REF REF='NEW HAMPSHIRE'), "STATE OF 
RESIDENCE"); 
%VARDOSES(2, STATE(PARAM=REF REF='WISCONSIN'), "STATE OF RESIDENCE"); 
%VARDOSES(3, STATE(PARAM=REF REF='DISTRICT OF COLUMBIA'), "STATE OF 
RESIDENCE"); 
%VARDOSES(4, STATE(PARAM=REF REF='WYOMING'), "STATE OF RESIDENCE"); 
 
ODS HTML CLOSE; 
 
 
 
 
 
 
